11
NEWS
Taking care
A newly available CGM sends insightful data to a
smart-phone via an app.
A
new user-friendly CGM
from Spirit Health is now
available on the UK's Drug
Tariff, meaning that NHS
diabetes care teams to prescribe
to people with diabetes who fit the
criteria for its use. With this, Spirit
Health intends to improve diabetes
management with its affordability,
simplicity and cutting-edge features,
offering more choice for people with
diabetes (PWDs).
CareSens Air is a 15-day wear
device that delivers glucose readings
directly to a user's smartphone,
enabling real-time monitoring and
empowering users to take control of
their health. With a slim, lightweight
design and all-in-one applicator,
the system ensures a seamless
experience for PWDs
Chris Barker, Chief Executive of
Spirit Health, says, "We're thrilled to
bring CareSens Air to the Drug Tariff
this February. This innovative device
bridges critical gaps in diabetes
care by offering a reliable tool that
enhances patient outcomes while
being mindful of healthcare budgets,
making healthcare simpler and more
accessible for all."
'Appy days
The CareSens Air app elevates diabetes
management with features
including real-time trend tracking,
personalised alerts for glucose
levels, and lifelong integration to
help users understand how daily
activities influence their health.
The app's remote monitoring
capability also allows healthcare
professionals and carers to access
live glucose data, detailed reports,
and actionable insights, supporting
proactive patient care.
Spirit Health works with partners,
including the NHS, to deliver
solutions tailored to their needs,
backed by evidence and awardwinning expertise.
Guided by a
holistic approach and a culture of
innovation, the Spirit Health team of
clinical and non-clinical professionals
ensures every service is centred
around people living with diabetes
and their healthcare partners.
www.spirit-health.com
This innovative
device bridges
critical gaps in
diabetes care.
~ Chris Barker